ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 60 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $241,411 | -33.1% | 740,524 | -11.7% | 0.00% | – |
| Q1 2023 | $360,641 | -18.6% | 838,702 | +0.3% | 0.00% | – |
| Q4 2022 | $443,144 | -27.5% | 836,120 | +0.2% | 0.00% | – |
| Q3 2022 | $611,000 | -36.5% | 834,752 | -1.1% | 0.00% | – |
| Q2 2022 | $962,000 | -44.0% | 843,683 | +0.6% | 0.00% | – |
| Q1 2022 | $1,719,000 | -28.6% | 838,459 | +0.3% | 0.00% | – |
| Q4 2021 | $2,407,000 | -32.5% | 835,648 | -0.7% | 0.00% | – |
| Q3 2021 | $3,567,000 | -12.9% | 841,153 | +8.6% | 0.00% | – |
| Q2 2021 | $4,096,000 | +48.1% | 774,264 | +30.1% | 0.00% | – |
| Q1 2021 | $2,766,000 | +106.6% | 595,021 | +46.6% | 0.00% | – |
| Q4 2020 | $1,339,000 | +4.5% | 405,918 | +4.9% | 0.00% | – |
| Q3 2020 | $1,281,000 | -13.3% | 387,125 | -11.7% | 0.00% | – |
| Q2 2020 | $1,478,000 | -74.4% | 438,643 | -70.9% | 0.00% | – |
| Q1 2020 | $5,779,000 | -36.8% | 1,508,608 | -0.3% | 0.00% | – |
| Q4 2019 | $9,143,000 | -16.3% | 1,513,605 | +4.8% | 0.00% | – |
| Q3 2019 | $10,923,000 | -38.6% | 1,444,781 | +10.1% | 0.00% | -100.0% |
| Q2 2019 | $17,778,000 | +1003.5% | 1,311,995 | +341.4% | 0.00% | – |
| Q1 2019 | $1,611,000 | +80.4% | 297,246 | -1.2% | 0.00% | – |
| Q4 2018 | $893,000 | -63.3% | 300,949 | +0.9% | 0.00% | – |
| Q3 2018 | $2,435,000 | +4.9% | 298,355 | +25.2% | 0.00% | – |
| Q2 2018 | $2,322,000 | -62.6% | 238,357 | -66.7% | 0.00% | – |
| Q1 2018 | $6,216,000 | -26.8% | 715,185 | +5.4% | 0.00% | – |
| Q4 2017 | $8,497,000 | +51.4% | 678,697 | +1.1% | 0.00% | – |
| Q3 2017 | $5,614,000 | -49.9% | 671,606 | +1.8% | 0.00% | -100.0% |
| Q2 2017 | $11,196,000 | +180.7% | 659,698 | +232.4% | 0.00% | – |
| Q1 2017 | $3,989,000 | – | 198,483 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ETF MANAGERS GROUP, LLC | 3,662,342 | $7,874,000 | 0.16% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 213,469 | $438,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 150,914 | $309,000 | 0.04% |
| Bernardo Wealth Planning LLC | 30,469 | $62,000 | 0.03% |
| Penserra Capital Management LLC | 351,154 | $719,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 175,900 | $361,000 | 0.01% |
| Founders Capital Management | 3,000 | $9,000 | 0.01% |
| King Wealth Management Group | 16,000 | $33,000 | 0.01% |
| Aquatic Capital Management LLC | 1,900 | $4,000 | 0.01% |
| Newbridge Financial Services Group, Inc. | 6,075 | $12,000 | 0.01% |